144 related articles for article (PubMed ID: 7932417)
21. Antiphospholipid syndrome and recurrent thrombosis in children.
Berkun Y; Padeh S; Barash J; Uziel Y; Harel L; Mukamel M; Revel-Vilk S; Kenet G
Arthritis Rheum; 2006 Dec; 55(6):850-5. PubMed ID: 17139660
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study.
de Bandt M; Benali K; Guillevin L; Hachulla E; Job C; Fautrel B; Fournié G; Bonnet C; Fournié B; Le Goff P; Jorgensen C; Meyer O
J Rheumatol; 1999 Jan; 26(1):91-6. PubMed ID: 9918247
[TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
Seaman DE; Londino AV; Kwoh CK; Medsger TA; Manzi S
Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
[TBL] [Abstract][Full Text] [Related]
24. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
26. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
28. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus.
Nossent JC; Swaak AJ
Q J Med; 1991 Jul; 80(291):605-12. PubMed ID: 1946940
[TBL] [Abstract][Full Text] [Related]
30. Association of the Charlson comorbidity index with mortality in systemic lupus erythematosus.
Jönsen A; Clarke AE; Joseph L; Belisle P; Bernatsky S; Nived O; Bengtsson AA; Sturfelt G; Pineau CA
Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1233-7. PubMed ID: 21618451
[TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
Avcin T; Silverman ED
Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
[TBL] [Abstract][Full Text] [Related]
32. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
[TBL] [Abstract][Full Text] [Related]
33. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia
Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784
[TBL] [Abstract][Full Text] [Related]
34. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A
Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112
[TBL] [Abstract][Full Text] [Related]
35. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
[TBL] [Abstract][Full Text] [Related]
36. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases.
Tănăsescu R; Nicolau A; Caraiola S; Ticmeanu M; Cojocaru IM; Frăsineanu A; Ionescu R; Hristea A; Ene A; Anghel D; Tănăsescu R; Băicuş C
Rom J Intern Med; 2007; 45(4):355-63. PubMed ID: 18767411
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
38. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
39. Features associated with epilepsy in the antiphospholipid syndrome.
Shoenfeld Y; Lev S; Blatt I; Blank M; Font J; von Landenberg P; Lev N; Zaech J; Cervera R; Piette JC; Khamashta MA; Bertolaccini ML; Hughes GR; Youinou P; Meroni PL; Pengo V; Alves JD; Tincani A; Szegedi G; Lakos G; Sturfelt G; Jönsen A; Koike T; Sanmarco M; Ruffatti A; Ulcova-Gallova Z; Praprotnik S; Rozman B; Lorber M; Chapman J; van-Breda-Vriezman PJ; Damoiseaux J
J Rheumatol; 2004 Jul; 31(7):1344-8. PubMed ID: 15229954
[TBL] [Abstract][Full Text] [Related]
40. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome.
Guballa N; Sammaritano L; Schwartzman S; Buyon J; Lockshin MD
Arthritis Rheum; 2000 Mar; 43(3):550-6. PubMed ID: 10728747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]